InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,524.40
(
0.60%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.65
(
-0.06%
)
Bitcoin
65,649.96
(
1.05%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: genisi post# 153409

Tuesday, 12/04/2012 10:28:58 PM

Tuesday, December 04, 2012 10:28:58 PM

Post# of 252255

So, I think it's quite possible that GILD's NS5A GS-5885 can produce similar results.




Two weeks ago GILD added Arm-17, and Arm-18 to this ongoing study. So testing of Sofosbuvir/GS-5885 and Sofosbuvir/5885/riba in GT2/GT3 has begun.



http://clinicaltrials.gov/ct2/show/NCT01260350?term=gs-5885&rank=10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up